慢性筋骨格疾患の管理におけるセレコキシブの安全性に関する現在のエビデンス: 総括的なレビュー
Charlotte Beaudart1, Christian Brabant2, Majed Alokail3
1Public Health Aging Research & Epidemiology (PHARE) Group, Research Unit in Clinical, Pharmacology and Toxicology (URPC), NAmur Research Institute for LIfe Sciences (NARILIS), Faculty of Medicine, University of Namur, Namur, Belgium. charlotte.beaudart@unamur.be.
Drugs
|September 5, 2025
まとめ
セレコキシブは,非選択的NSAIDよりも慢性的な運動器系疾患に対する安全性を示しています. 心血管と腎臓の安全性は比較可能だが,証拠の質は低いため,さらなる研究が必要である.
科学分野:
- 薬理学と治療法
- 証拠の統合とメタ分析
- リウマトロジ
背景:
- 慢性的な運動器系疾患は,骨格関節炎や関節リウマチなど,生活の質に大きな影響を与えます.
- 非ステロイド性抗炎症薬 (NSAID) は,痛みや炎症に一般的に使用されますが,リスクがあります.
- 選択的なCOX-2阻害剤であるセレコキシブは,潜在的に異なる安全性プロファイルを持つ代替品を提供します.
研究 の 目的:
- 慢性的な運動障害を持つ成人のセレコキシブの安全性に関する既存のメタシンセシスを体系的に合成し,評価する.
- セレコキシブの胃腸,心血管,腎臓,全因死亡の安全性を,プラセボおよび非選択性NSAIDと比較して評価する.
主な方法:
- PRISMA 2020ガイドラインに準拠した総括審査方法論
- MEDLINE,Cochrane Central,およびScopusのデータベースを介して,包括的な文献検索を行いました.
- AMSTAR-2を用いたバイアスのリスクとGRADEを用いた証拠分類の確実性
主要な成果:
- セレコキシブは,非選択的NSAIDと比較して,胃腸潰瘍および胃腸イベントのリスクを低めた.
- 選択的でないNSAIDと比較して,心臓血管疾患に対する安全性評価は一般的であった.ある研究では,セレコキシブによる心臓血管疾患による死亡リスクが低かったことが示された.
- すべての原因による死亡に関する証拠は限られていたが,非選択的NSAIDよりも潜在的に低いリスクを示唆した.
結論:
- セレコキシブは,非選択的NSAIDと比較して,運動器系疾患に対する優れた胃腸安全性を提供します.
- 心血管,腎臓,および死亡率の潜在的な利点が示唆されているが,その証拠は低い確実性と限られている.
- ランダム化試験と観察データを統合したさらなる研究は,包括的な長期的な安全性評価とパーソナライズされた治療に不可欠です.
関連する概念動画
01:21Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
01:21Skeletal Muscle Relaxants: Adverse Effects
467
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
467
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
200
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
200
01:29Inflammatory Bowel Disease IV: Pharmacological Management
177
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
177
01:31Skeletal Muscle Relaxants: Therapeutic Uses
612
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
612
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
230
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
230